Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.
作者信息
Bahji Anees, Danilewitz Marlon, Sloan Matthew, Tang Victor, Crockford David
机构信息
Psychiatrist, Department of Psychiatry, University of Calgary, Calgary, Alta.
Psychiatrist, Department of Psychiatry, University of Toronto, Toronto, Ont.
出版信息
CMAJ. 2024 Mar 17;196(10):E346-E347. doi: 10.1503/cmaj.149917-l.
Abstract
摘要
相似文献
1
Concerns regarding the recommendation against prescribing selective serotonin reuptake inhibitors in the Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.关于加拿大高危饮酒和酒精使用障碍临床管理指南中反对开具选择性5-羟色胺再摄取抑制剂的建议的相关担忧。
CMAJ. 2024 Mar 17;196(10):E346-E347. doi: 10.1503/cmaj.149917-l.
2
Navigating the nuances of the Canadian guideline's stance on selective serotonin reuptake inhibitors in concurrent alcohol use disorder and mood or anxiety disorders.解读加拿大指南对于在同时患有酒精使用障碍及情绪或焦虑障碍时使用选择性5-羟色胺再摄取抑制剂的立场的细微差别。
CMAJ. 2024 Mar 17;196(10):E348. doi: 10.1503/cmaj.150034-l.
3
Use of serotonin (5-hydroxytryptamine) reuptake inhibitors in the treatment of alcoholism.血清素（5-羟色胺）再摄取抑制剂在酒精中毒治疗中的应用。
Alcohol Alcohol Suppl. 1996 Mar;31(1):69-75.
4
Pharmacotherapy in alcoholism treatment: integrating and understanding the use of serotonin reuptake inhibitors.
Alcohol Alcohol Suppl. 1994;2:537-43.
5
The role of selective serotonin reuptake inhibitors in reducing alcohol consumption.选择性5-羟色胺再摄取抑制剂在减少酒精摄入方面的作用。
J Clin Psychiatry. 2001;62 Suppl 20:18-25.
6
Occurrence and management of depression in the context of naltrexone treatment of alcoholism.纳曲酮治疗酒精中毒过程中抑郁症的发生与管理
Am J Psychiatry. 1999 Aug;156(8):1258-62. doi: 10.1176/ajp.156.8.1258.
7
The use of selective serotonin reuptake inhibitors in treating alcoholic subtypes.选择性5-羟色胺再摄取抑制剂在治疗酒精相关亚型中的应用。
J Clin Psychiatry. 2001;62 Suppl 20:26-31.
8
Effect of Selective Serotonin Reuptake Inhibitors on Healthcare Utilization in Patients with Post-Traumatic Stress Disorder and Alcohol Use Disorder.选择性 5-羟色胺再摄取抑制剂对创伤后应激障碍和酒精使用障碍患者医疗利用的影响。
Alcohol Alcohol. 2019 Jul 1;54(4):428-434. doi: 10.1093/alcalc/agz045.
9
Serotonin and alcohol drinking.
NIDA Res Monogr. 1992;119:141-5.
10
[SSRI antidepressants and alcoholism].
Rev Med Liege. 2000 Nov;55(11):1003-10.
引用本文的文献
1
Integrated Management of Co-Occurring Alcohol Use Disorder and Depression: Clinical Approaches for Concurrent Disorders.酒精使用障碍与抑郁症共病的综合管理：并发疾病的临床方法
Can J Psychiatry. 2025 Sep 3:7067437251374564. doi: 10.1177/07067437251374564.
2
[Not Available].[无可用内容]
CMAJ. 2024 May 20;196(19):E689-E690. doi: 10.1503/cmaj.150095-l-f.
3
Addressing the risks of antidepressants among people with alcohol use disorders.应对酒精使用障碍患者使用抗抑郁药的风险。
CMAJ. 2024 Mar 17;196(10):E349-E350. doi: 10.1503/cmaj.150095-l.
本文引用的文献
1
Canadian guideline for the clinical management of high-risk drinking and alcohol use disorder.加拿大高危饮酒和酒精使用障碍临床管理指南。
CMAJ. 2023 Oct 16;195(40):E1364-E1379. doi: 10.1503/cmaj.230715.
2
Treatment outcomes in major depressive disorder in patients with comorbid alcohol use disorder: A STAR*D analysis.伴有酒精使用障碍的重性抑郁障碍患者的治疗结局：一项 STAR*D 分析。
J Affect Disord. 2023 Oct 15;339:691-697. doi: 10.1016/j.jad.2023.07.049. Epub 2023 Jul 17.
3
Pharmacological Treatment of Mood Disorders and Comorbid Addictions: A Systematic Review and Meta-Analysis: Traitement Pharmacologique des Troubles de L'humeur et des Dépendances Comorbides: Une Revue Systématique et une Méta-Analyse.心境障碍和共病成瘾的药物治疗：系统评价和荟萃分析：共病性心境障碍和成瘾的药物治疗：系统评价和荟萃分析。
Can J Psychiatry. 2020 Nov;65(11):749-769. doi: 10.1177/0706743720915420. Epub 2020 Apr 17.
4
Antidepressants for the treatment of people with co-occurring depression and alcohol dependence.用于治疗同时患有抑郁症和酒精依赖症患者的抗抑郁药。
Cochrane Database Syst Rev. 2018 Apr 24;4(4):CD008581. doi: 10.1002/14651858.CD008581.pub2.
5
Poorer Drinking Outcomes with Citalopram Treatment for Alcohol Dependence: A Randomized, Double-Blind, Placebo-Controlled Trial.西酞普兰治疗酒精依赖的饮酒结局较差：一项随机、双盲、安慰剂对照试验。
Alcohol Clin Exp Res. 2015 Sep;39(9):1756-65. doi: 10.1111/acer.12802. Epub 2015 Jul 24.
6
Pharmacotherapy for anxiety and comorbid alcohol use disorders.焦虑症合并酒精使用障碍的药物治疗
Cochrane Database Syst Rev. 2015 Jan 20;1(1):CD007505. doi: 10.1002/14651858.CD007505.pub2.
7
Effects of independent and substance-induced major depressive disorder on remission and relapse of alcohol, cocaine and heroin dependence.独立和物质引起的重度抑郁症对酒精、可卡因和海洛因依赖的缓解和复发的影响。
Addiction. 2013 Jan;108(1):115-23. doi: 10.1111/j.1360-0443.2012.04010.x. Epub 2012 Oct 5.
8
Effect of concurrent substance use disorder on the effectiveness of single and combination antidepressant medications for the treatment of major depression: an exploratory analysis of a single-blind randomized trial.合并物质使用障碍对单一和联合抗抑郁药物治疗重度抑郁症疗效的影响：一项单盲随机试验的探索性分析。
Depress Anxiety. 2012 Feb;29(2):111-22. doi: 10.1002/da.20918.
9
Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.共病物质使用障碍是否会影响使用 SSRI 治疗重度抑郁症的康复？STAR*D 一级治疗结果的分析。
Drug Alcohol Depend. 2010 Mar 1;107(2-3):161-70. doi: 10.1016/j.drugalcdep.2009.10.003. Epub 2009 Nov 28.
10
Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.氟西汀治疗伴有酒精使用障碍的青少年共病重性抑郁的双盲安慰剂对照试验。
Addict Behav. 2009 Oct;34(10):905-9. doi: 10.1016/j.addbeh.2009.03.008. Epub 2009 Mar 12.
Zotero 插件